VIR vs. BND
Compare and contrast key facts about Vir Biotechnology, Inc. (VIR) and Vanguard Total Bond Market ETF (BND).
BND is a passively managed fund by Vanguard that tracks the performance of the Barclays Capital U.S. Aggregate Bond Index. It was launched on Apr 3, 2007.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VIR or BND.
Correlation
The correlation between VIR and BND is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VIR vs. BND - Performance Comparison
Key characteristics
VIR:
-0.36
BND:
0.31
VIR:
-0.16
BND:
0.46
VIR:
0.98
BND:
1.05
VIR:
-0.25
BND:
0.12
VIR:
-0.85
BND:
0.87
VIR:
27.19%
BND:
1.91%
VIR:
64.13%
BND:
5.43%
VIR:
-91.89%
BND:
-18.84%
VIR:
-91.10%
BND:
-9.27%
Returns By Period
In the year-to-date period, VIR achieves a -26.54% return, which is significantly lower than BND's 1.48% return.
VIR
-26.54%
6.64%
-17.43%
-23.10%
-9.66%
N/A
BND
1.48%
-0.24%
1.41%
1.67%
-0.34%
1.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VIR vs. BND - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Vanguard Total Bond Market ETF (BND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VIR vs. BND - Dividend Comparison
VIR has not paid dividends to shareholders, while BND's dividend yield for the trailing twelve months is around 3.62%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Vanguard Total Bond Market ETF | 3.62% | 3.09% | 2.60% | 1.97% | 2.22% | 2.72% | 2.81% | 2.54% | 2.51% | 2.57% | 2.79% | 2.78% |
Drawdowns
VIR vs. BND - Drawdown Comparison
The maximum VIR drawdown since its inception was -91.89%, which is greater than BND's maximum drawdown of -18.84%. Use the drawdown chart below to compare losses from any high point for VIR and BND. For additional features, visit the drawdowns tool.
Volatility
VIR vs. BND - Volatility Comparison
Vir Biotechnology, Inc. (VIR) has a higher volatility of 22.29% compared to Vanguard Total Bond Market ETF (BND) at 1.65%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than BND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.